Sequoia Financial Advisors LLC Sells 806 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Sequoia Financial Advisors LLC reduced its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 3.1% in the first quarter, according to its most recent filing with the SEC. The fund owned 25,535 shares of the company’s stock after selling 806 shares during the period. Sequoia Financial Advisors LLC’s holdings in Privia Health Group were worth $573,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. EverSource Wealth Advisors LLC lifted its stake in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after acquiring an additional 2,350 shares during the last quarter. Bessemer Group Inc. lifted its stake in shares of Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock worth $51,000 after acquiring an additional 2,178 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock worth $64,000 after acquiring an additional 1,521 shares during the last quarter. Financial Management Professionals Inc. lifted its stake in shares of Privia Health Group by 28.7% during the 1st quarter. Financial Management Professionals Inc. now owns 3,383 shares of the company’s stock worth $76,000 after acquiring an additional 754 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its stake in shares of Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock worth $95,000 after acquiring an additional 511 shares during the last quarter. 94.48% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on PRVA shares. Robert W. Baird raised their price target on Privia Health Group from $24.00 to $26.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 15th. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 target price on shares of Privia Health Group in a research report on Thursday, April 10th. Truist Financial lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the company a “buy” rating in a research report on Thursday, April 10th. JPMorgan Chase & Co. lifted their target price on Privia Health Group from $29.00 to $32.00 and gave the company an “overweight” rating in a research report on Wednesday, May 28th. Finally, Barclays lifted their target price on Privia Health Group from $23.00 to $24.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 27th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Privia Health Group currently has an average rating of “Buy” and a consensus price target of $27.77.

Privia Health Group Trading Down 2.0%

PRVA opened at $22.54 on Wednesday. The firm has a market cap of $2.75 billion, a price-to-earnings ratio of 187.85, a PEG ratio of 3.68 and a beta of 0.82. Privia Health Group, Inc. has a 12 month low of $16.47 and a 12 month high of $26.09. The stock has a fifty day moving average price of $23.16 and a 200-day moving average price of $22.88.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 15,100 shares of the business’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total value of $352,283.00. Following the completion of the transaction, the chief executive officer directly owned 454,281 shares of the company’s stock, valued at approximately $10,598,375.73. The trade was a 3.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Matthew Shawn Morris sold 10,309 shares of the business’s stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $23.33, for a total value of $240,508.97. Following the completion of the transaction, the director directly owned 59,792 shares of the company’s stock, valued at approximately $1,394,947.36. The trade was a 14.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 45,949 shares of company stock valued at $1,100,368. Corporate insiders own 10.70% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.